A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas

PURPOSE: Patients with metastatic or recurrent Ewing’s sarcoma (ESFT) and alveolar rhabdomyosarcoma (AR) have <25% 5-yr. survival in most studies. This study administered a novel immunotherapy regimen aimed at consolidating remission in these patients. EXPERIMENTAL DESIGN: 52 patients with transl...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mackall, Crystal L., Rhee, Eunice H., Read, Elizabeth J., Khuu, Hanh M., Leitman, Susan F., Bernstein, Donna, Tesso, Merertu, Long, Lauren M., Grindler, David, Merino, Margret, Kopp, William, Tsokos, Maria, Berzofsky, Jay A., Helman, Lee J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2497450/
https://ncbi.nlm.nih.gov/pubmed/18676758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-07-4065
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky